The authors postulated that BCL11B is a haploinsufficient tumor suppressor that collaborates with all major T-ALL oncogenic lesions in human thymocyte transformation, although this has not been confirmed in functional studies. The gene discussed is BCL11B; the disease is acute lymphoblastic leukemia.